Transplant

• 

  All Medical News

  EHA 2016: Consolidation and maintenance therapy for multiple myeloma: is it the new standard? Professor Paul Richardson (Harvard Medical School, Boston, USA) and Professor Maria-Victoria Mateos (Salamanca, Spain) discuss the meta-analysis of OS in myeloma with maintenance therapy presented at ASCO and EHA this year, along with strategies for continuous therapies

  Written by Lorraine Carolan | 3 Aug 2016

  Consolidation and maintenance therapy for multiple myeloma: is it the new standard?   Professor Antonio Palumbo (University of Turin, Italy) and Professor Paul Richardson (Harvard Medical School, Boston,… read more.

• 

  All Medical News

  EHA 2016: Pathophysiology and diagnosis of multiple myeloma bone disease. The chair of this year’s EHA educational session on myeloma, Professor Roman Hajek (University of Ostrava, Czech Republic), discusses highlights from the session.

  Written by Lorraine Carolan | 2 Aug 2016

  Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.

• 

  All Medical News

  EHA 2016: Pathophysiology and diagnosis of multiple myeloma bone disease. The chair of this year's EHA educational session on myeloma, Professor Roman Hajek (University of Ostrava, Czech Republic), discusses highlights from the session.

  Written by Lorraine Carolan | 2 Aug 2016

  Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.

• 

  All Medical News

  EHA 2016: A new multiple myeloma classification system that correlates to disease stage and prognosis

  Written by Lorraine Carolan | 29 Jul 2016

  Hans Erik Johnsen, Aalborg University Hospital, Denmark. by Maria Dalby:  The gene expression profiles of myeloma plasma cells in the normal bone marrow can be used for defining… read more.

• 

  All Medical News

  EHA 2016: Managing multiple myeloma in elderly/frail patients. Professor Antonio Palumbo (University of Torino, Italy) discusses the impact of age on outcomes (abstract E1295) and Professor Roman Hajek (University of Ostrava, Czech Republic) talks about preferred therapeutic strategies for elderly MM patients.

  Written by Lorraine Carolan | 20 Jul 2016

  Managing multiple myeloma in elderly/frail patients   Although multiple myeloma is a disease of old age, elderly patients vary a great deal in terms of fitness and ability… read more.

• 

  All Medical News

  EHA 2016: Preventing clonal evolution in multiple myeloma – evidence from clinical trials. Professor Roman Hájek from the Czech Republic discussed the clinical implications of clonal evolution in multiple myeloma (MM) and summarised the latest clinical data.

  Written by Lorraine Carolan | 19 Jul 2016

  Preventing clonal evolution in multiple myeloma – evidence from clinical trials by Maria Dalby Professor Roman Hájek from the Czech Republic discussed the clinical implications of clonal evolution… read more.

• 

  All Medical News

  EHA 2016: How monoclonal antibodies will change the treatment of multiple myeloma. Professor Antonio Palumbo (Torino, Italy) discuss the results of the CASTOR trial and Professor Meletios-Athanasios Dimopoulos (Athens, Greece) discussing POLLUX.

  Written by Lorraine Carolan | 15 Jul 2016

  How monoclonal antibodies will change the treatment of multiple myeloma  by Maria Dalby   Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France Meletios Dimopoulos, University of Athens School of… read more.

• 

  All Medical News

  EHA 2016: Professor Kwee Yong (London) and Dr Mark Cook (Birmingham) share EHA highlights that will affect practice in the UK, including excitement around daratumumab and where research in the molecular stratification of disease is guiding practice. Professor Sagar Lonial (Atlanta) shares his highlights of EHA and ASCO, including data confirming the benefit of maintenance therapy and of transplant, and Professor Roman Hajek (Ostrava) gives a reality check on what the new data means for patients and haematolgists.

  Written by Lorraine Carolan | 14 Jul 2016

• 

  All Medical News

  Pioglitazone shows efficacy against a chronic liver disease

  Written by Bruce Sylvester | 11 Jul 2016

  by Bruce Sylvester: Pioglitazone shows efficacy against the progression of nonalcoholic steatohepatitis, or NASH, a chronic liver disease caused by a buildup of fat. Researchers reported this finding… read more.

• 

  All Medical News

  ILTS 2016: Professor John O’Grady (Kings College Hospital, London) discusses current practices in managing HCV. Also included associated article.

  Written by Lorraine Carolan | 17 Jun 2016

  Treating patients with Hepatitis C infections who are on the liver transplant waiting list is not a given by Thomas R. Collins: What if patients are too sick… read more.

• 

  All Medical News

  ILTS 2016: Oral Abstract highlights: Dr Leslie Lilly and Markus Selzner (both of UHN Toronto General Hospital, ON, Canada) give a round-up of the abstracts that most caught their attention at ILTS 2016.

  Written by Lorraine Carolan | 16 Jun 2016

• 

  All Medical News

  ILTS 2016: Hepatocellular Carcinoma: Size and number vs biology: Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.

  Written by Lorraine Carolan | 15 Jun 2016